Hepatocellular carcinoma treated with sorafenib

被引：2
|
作者：
Han, G. [1 ]
Zhao, Y. [1 ]
Qi, X. [1 ]
Fan, D. [1 ,2 ]
机构：
[1] Fourth Mil Med Univ, Dept Liver Dis & Digest Intervent Radiol, Xijing Hosp Digest Dis, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2011年 / 34卷 / 11-12期
关键词：
PROGNOSTIC INDICATORS; CIRRHOSIS;
D O I：
10.1111/j.1365-2036.2011.04852.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1347 / 1348
页数：2
相关论文
共 50 条
  • [1] Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
    Ko, Yi-Ling
    Takata, Kazuhide
    Tanaka, Takashi
    Ohishi, Jun
    Takeshita, Morishige
    Yamauchi, Ryo
    Fukuda, Hiromi
    Miyayama, Takashi
    Uchida, Yotaro
    Yokoyama, Keiji
    Morihara, Daisuke
    Takeyama, Yasuaki
    Shakado, Satoshi
    Sakisaka, Shotaro
    Hirai, Fumihito
    CASE REPORTS IN GASTROENTEROLOGY, 2020, 14 (01) : 226 - 233
  • [2] Hepatocellular carcinoma treated with sorafenib: authors' reply
    Peck-Radosavljevic, M.
    Pinter, M.
    Sieghart, W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (11-12) : 1348 - 1349
  • [3] The prognostic markers in hepatocellular carcinoma treated with sorafenib
    Kawasaki, Takeshi
    Tokunaga, Takayuki
    Fujie, Satomi
    Yoshimaru, Yoko
    Watanabe, Takehisa
    Setoyama, Hiroko
    Tateyama, Masakuni
    Tanaka, Motohiko
    Sasaki, Yutaka
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 419 - 419
  • [4] Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib
    Pomej, Katharina
    Scheiner, Bernhard
    Park, Dabin
    Bauer, David
    Balcar, Lorenz
    Meischl, Tobias
    Mandorfer, Mattias
    Reiberger, Thomas
    Muller, Christian
    Trauner, Michael
    Pinter, Matthias
    CANCERS, 2020, 12 (10) : 1 - 14
  • [5] Remission of Psoriasis in a Patient with Hepatocellular Carcinoma Treated with Sorafenib
    Antoniou, Efstathios A.
    Koutsounas, Ioannis
    Damaskos, Christos
    Koutsounas, Sotiris
    IN VIVO, 2016, 30 (05): : 677 - 680
  • [6] Advanced hepatocellular carcinoma treated by a combination of sorafenib and radiotherapy
    Yang, Bi-Ling
    Yeh, Chun
    Hsu, Chung-Te
    Chang, Tien-Yu
    Wang, Chung-Yih
    ADVANCES IN DIGESTIVE MEDICINE, 2014, 1 (01) : 25 - 29
  • [7] Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenib
    Cabibbo, Giuseppe
    Rolle, Emanuela
    De Giorgio, Massimo
    Genco, Chiara
    Pressiani, Tiziana
    Spada, Francesca
    Sacco, Rodolfo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (12) : 1807 - 1816
  • [8] Liver transplantation in a patient treated by sorafenib for hepatocellular carcinoma
    Borentain, P.
    Gregoire, E.
    Hardwigsen, J.
    Garcia, S.
    Durieux, O.
    Le Treut, Y. -P.
    Gerolami, R.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (03) : 234 - 236
  • [9] Biological downstaging of intermediate hepatocellular carcinoma in patients treated with sorafenib
    Vitale, A.
    Morales, R. Ramirez
    Cillo, U.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S89 - S89
  • [10] Effects of Home Care on patients with hepatocellular carcinoma treated with sorafenib
    Moser, Monika
    Radu, Iuliana-Pompilia
    Dufour, Jean-Francois
    JGH OPEN, 2021, 5 (08): : 864 - 870
12345